Braden William Fenske Insider Profile
4 Followers
Braden William Fenske, Chief Strategy Officer at MediPharm Labs, holds 11.01K shares in MediPharm Labs (Ticker: MEDIF). Most recently, Braden William Fenske Bought 2,000 shares of MediPharm Labs on Jun 25, 2019 for an estimated value of $9.60K.
Braden William Fenske's Trading History
| MEDIFMediPharm Labs | Jun 25, 2019 | Chief Strategy Officer | Informative Buy | 9.60K | $484.40 | ||||||||||||||||||||||
MEDIF Insider Shares: 11.01K (0.85%)
| |||||||||||||||||||||||||||
You May Also Like
Braden William Fenske insider profile FAQ
What is the percentage of profitable transactions made by Braden William Fenske?
The percentage of profitable transactions made by Braden William Fenske is 0%.
What is the average return per transaction made by Braden William Fenske?
The average return per transaction made by Braden William Fenske is -73.60%.
What stocks does Braden William Fenske hold?
Braden William Fenske holds: MEDIF stocks.
What was Braden William Fenske’s latest transaction?
Braden William Fenske’s latest transaction was an Informative Buy of $9.60K.
What was Braden William Fenske's most profitable transaction?
Braden William Fenske’s most profitable transaction was an Informative Buy of MEDIF stock on June 22, 2019. The return on the trade was -73.00%.
What is Braden William Fenske's role in MediPharm Labs?
Braden William Fenske's role in MediPharm Labs is Chief Strategy Officer.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.
TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.
